HGF and obesity disorder: Interestingly, PAI-1 has been reported to reduce the amount of active HGF [30], a cytokine that increases glucose transport ex vivo in the skeletal muscle [31] and whose overexpression in this tissue counteracts muscle insulin resistance and improves glucose tolerance in an animal model of obesity [32].